|
Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trial |
|
|
|
Titel: |
Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trial |
Auteur: |
Ogbuagu, Onyema Segal-Maurer, Sorana Ratanasuwan, Winai Avihingsanon, Anchalee Brinson, Cynthia Workowski, Kimberly Antinori, Andrea Yazdanpanah, Yazdan Trottier, Benoit Wang, Hui Margot, Nicolas Dvory-Sobol, Hadas Rhee, Martin S Baeten, Jared M Molina, Jean-Michel |
Verschenen in: |
The Lancet. HIV |
Paginering: |
Jaargang 10 () nr. 8 pagina's e497-e505 |
Jaar: |
2023 |
Inhoud: |
|
Uitgever: |
Elsevier Ltd |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|